0MSD.L LSE
CompuGroup Medical SE & Co. KGaA
1W: +inf%
1M: -0.9%
3M: +0.5%
YTD: +2.4%
€41.50
Last traded 2026-06-30 — delisted
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$129M
-28.2% ▼
5Y CAGR: +3.1%
Capital Expenditures
$63M
+16.2% ▲
5Y CAGR: +7.6%
Free Cash Flow
$66M
-36.9% ▼
5Y CAGR: -0.3%
Dividends Paid
$52M
-98.1% ▼
Buybacks
$15M
+0.0% ▲
Net Change in Cash
$43M
+264.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $73M | $69M | $74M | $47M | $35M |
| Depreciation & Amort. | $76M | $111M | $112M | $116M | $112M |
| Stock-Based Comp. | $6M | $6M | $0 | $0 | $0 |
| Change in Working Capital | -$12M | $4M | -$43M | -$9M | $16M |
| Other Non-Cash Items | $983K | -$20M | $2M | $26M | -$34M |
| Operating Cash Flow | $150M | $165M | $145M | $180M | $129M |
| — Investing Activities — | |||||
| Capital Expenditures | -$56M | -$77M | -$81M | -$19M | -$63M |
| Acquisitions (Net) | -$400M | -$94M | -$65M | -$50M | -$42M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$1M | $8M | $392K | -$55M | $427K |
| Investing Cash Flow | -$457M | -$164M | -$145M | -$124M | -$105M |
| — Financing Activities — | |||||
| Net Debt Issuance | $42M | $174M | $45M | -$50M | $114M |
| Stock Repurchased | $0 | -$96M | -$9M | $0 | -$15M |
| Dividends Paid | -$24M | -$26M | -$26M | -$26M | -$52M |
| Other Financing | -$17M | -$21M | -$26M | -$5M | -$29M |
| Financing Cash Flow | $338M | $30M | -$16M | -$81M | $19M |
| Net Change in Cash | $30M | $31M | -$17M | -$26M | $43M |
| Cash End of Period | $76M | $107M | $91M | $64M | $107M |
| Free Cash Flow | $94M | $88M | $64M | $104M | $66M |